Volcano Corp. (VOLC) Financials Nov 14, 2014, 4:28

New Post Public Reply Private Reply Replies (0) Message Board
Hirata
Volcano Corp. (VOLC) Financials Nov 14, 2014, 4:28 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Volcano Corp.


Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 227.87M 294.15M 343.55M 381.87M 393.68M
Cost of Goods Sold (COGS) incl. D&A 95.71M 111.42M 117.98M 132.16M 161.05M
COGS excluding D&A 79.53M 92.72M 94.77M 108.65M 134.68M
Depreciation & Amortization Expense 16.18M 18.7M 23.21M 23.5M 26.36M
Depreciation 11.96M 16.14M 19.77M 20.26M 22.53M
Amortization of Intangibles 4.22M 2.56M 3.45M 3.24M 3.83M
Gross Income 132.15M 182.73M 225.57M 249.71M 232.63M
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 148.97M 175.69M 200.16M 228.26M 237.88M
Research & Development 37.37M 42.52M 53.1M 55.47M 55.34M
Other SG&A 111.6M 133.17M 147.06M 172.79M 182.53M
Other Operating Expense 0 0 0 0 0
Unusual Expense 14.03M (2.94M) 1.3M 6.83M 17.93M
EBIT after Unusual Expense (14.03M) 2.94M (1.3M) (6.83M) (17.93M)
Non Operating Income/Expense 2.33M (929,000) 191,000 2.14M (2.03M)
Non-Operating Interest Income 756,000 477,000 908,000 902,000 1.29M
Equity in Affiliates (Pretax) 0 0 0 - -
Interest Expense 5,000 2.19M 7.11M 7.98M 26.91M
Gross Interest Expense 5,000 2.19M 7.11M 9.61M 27.85M
Interest Capitalized - - - 1.64M 939,000
Pretax Income (27.77M) 7.33M 18.1M 9.69M (50.82M)
Income Tax 1.19M 2.09M (19.99M) 1.67M (16.33M)
Income Tax - Current Domestic 4.44M (2.21M) 498,000 207,000 224,000
Income Tax - Current Foreign 1.49M 1.59M 2.28M 2.47M 2M
Income Tax - Deferred Domestic (4.05M) 3.13M 3.59M 4.12M (19.03M)
Income Tax - Deferred Foreign (696,000) (426,000) (519,000) (214,000) 467,000
Income Tax Credits 0 0 25.84M 4.92M -
Equity in Affiliates 0 0 0 0 -
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income (28.95M) 5.24M 38.09M 8.02M (34.49M)
Minority Interest Expense 0 0 0 0 0
Net Income (28.95M) 5.24M 38.09M 8.02M (34.49M)
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 - 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries (28.95M) 5.24M 38.09M 8.02M (34.49M)
Preferred Dividends 0 0 0 0 0
Net Income Available to Common (28.95M) 5.24M 38.09M 8.02M (34.49M)
EPS (Basic) (0.60) 0.10 0.73 0.15 (0.63)
Basic Shares Outstanding 48.4M 50.55M 52.3M 53.48M 54.34M
EPS (Diluted) (0.60) 0.10 0.70 0.15 (0.63)
Diluted Shares Outstanding 48.4M 53.28M 54.6M 55.2M 54.34M
EBITDA (635,000) 25.74M 48.63M 44.95M 21.12M
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Ivonescimab Promises New Hope for Advanced BTC Patients

Updated Category News Views 337

Shifting the Paradigm in Biliary Tract Cancer Treatment Here's the scoop from the bustling world of oncology: the trial of Ivonescimab plus chemotherapy is stirring waves among experts in advanced biliary tract cancer (BTC). Contrary to the usual drowsy mornings with coffee and market pages, this data from Hong Kong wasn't about Wall Street this time. This trial might...

Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 296

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading
Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 416

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading
Love Business Group Helps SMEs Navigate Broadband Choices

Updated Category News Views 195

Understanding Broadband Needs for UK SMEs When you're knee-deep in running a small biz in the UK, sorting out your broadband needs can feel like sifting through a thousand-piece puzzle. Enter Love Business Group, getting a nod of recognition for being the SME knight in shining armor. Aimed at businesses of all sizes, they've been pegged by Expert Consumers for helping...

Continue Reading
D-Wave Investors Must Decide by Dec 15 Class Suit

Updated Category News Views 177

Facing the Class Action Deadline There's nothing like a looming deadline to stir the pot, and that's exactly what's happening with D-Wave Quantum Inc. (NASDAQ: QBTS) as it faces the heat of a class action lawsuit. Investors who got caught in the slide between February 26, 2026, and August 25, 2026, need to sharpen their pencils and mark December 15, 2026, on their...

Continue Reading
Monster Energy Unleashes Gaming Frenzy at Cosm L.A. Event

Updated Category News Views 271

Where Energy Drinks and Digital Reality Collide Monster Energy sure knows how to throw a party, especially when it hinges on something as electrifying as Call of Duty: Modern Warfare 4. Imagine this: Cosm Los Angeles is decked out with a massive 87-foot LED dome, and every gamer, celeb, and influencer ready to dive right in. You can't make this stuff up. They've mashed...

Continue Reading
TORRAS Cases Balance Protection with Slim Design for 2026

Updated Category News Views 260

Are Slim iPhone Cases Really Protecting Your Investment? Anyone who's dropped a brand-new phone knows the pain of watching your investment smack the concrete. But hey, welcome to 2026, where Consumer365's latest rundown on iPhone protective gear turns the spotlight on TORRAS. These folks grabbed attention with their Q3 Air and Q3 Air Pro cases, crafted for iPhone 18 Pro...

Continue Reading
RYBREVANT's Promising Results in HNSCC Treatment

Updated Category News Views 267

Impressive Outcomes for RYBREVANT FASPRO in Head and Neck Cancer Tucked away in the endless cycle of drug trials, a glimmer of hope shines through with new data on RYBREVANT FASPRO in treating head and neck squamous cell carcinoma (HNSCC). This science talk might not rattle the ticker tape directly on NYSE:JNJ, but it has all the makings of a game-changer in the oncology...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 258

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Gildan Activewear Faces Legal Battle Over Alleged Fraud

Updated Category News Views 196

Investor Alert: Gildan's Legal Showdown Alright, here's a twist you didn't see coming—or maybe you did if you've been tracking the ticker tapes like a hawk. Gildan Activewear Inc. (NYSE:GIL) is stuck in the kind of hot water that can scald the bottom line. The Stakes: Racing Towards December 14 Marked on your calendar, December 14, is a date of some significance if...

Continue Reading

Top 5 Most Recently Viewed Articles

Mesirow Recognized Among Top Money Management Workplaces Again

Updated Category News Views 156

Mesirow's Remarkable Recognition in Money Management Mesirow has just been honored by Pensions & Investments as a Best Places to Work in Money Management for the year 2025, marking the seventh occasion the firm has received this prestigious recognition. This accolade reflects Mesirow's unwavering commitment to fostering a workplace that prioritizes culture, employee...

Continue Reading
Follett and Bath & Body Works Team Up for Campus Retail Revolution

Updated Category News Views 275

Follett Higher Education Partners with Bath & Body Works This happy collaboration marks Follett Higher Education's new venture to enrich student life on college campuses across the nation. Follett, recognized as North America's largest campus retailer, is working with Bath & Body Works to bring their beloved bath and body products directly to students at more than 150...

Continue Reading
Understanding Recent Share Transactions of Planisware SA

Updated Category News Views 125

Overview of Planisware's Recent Share Transactions Planisware SA has recently undergone several notable transactions concerning its own shares. As a leader in project portfolio management software, the company's activities on the share market reflect its strong position and proactive approach in satisfying investor interests. Company Details Planisware SA is widely...

Continue Reading
Investor Alert: Lawsuit Against Iris Energy Limited Explained

Updated Category News Views 112

Overview of the Investor Lawsuit Against Iris Energy Limited The legal landscape for investors can often be complex, especially when serious allegations are involved. Recently, the national securities law firm, Faruqi & Faruqi, LLP, has initiated an investigation targeting Iris Energy Limited (NASDAQ: IREN) concerning potential securities law violations. The firm is...

Continue Reading
Warner Bros. Discovery Welcomes Anton Levy to Board

Updated Category News Views 166

Warner Bros. Discovery Welcomes Anton Levy to the Board Warner Bros. Discovery, Inc. (NASDAQ: WBD) is thrilled to announce the upcoming addition of Anton Levy to its Board of Directors as an independent member. This decision is part of the company's commitment to building a strong leadership team aimed at navigating the evolving media landscape. Anton Levy: A Wealth of...

Continue Reading